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Abstract Two antifungal peptides, named EAFP1 and EAFP2,
have been puri¢ed from the bark of Eucommia ulmoides Oliv.
Each of the sequences consists of 41 residues with a N-terminal
blockage by pyroglutamic acid determined by automated Edman
degradation in combination with the tandem mass spectroscopy
and the C-terminal ladder sequencing analysis. The primary
structurs all contain 10 cysteines, which are cross-linked to
form ¢ve disul¢de bridges with a pairing pattern (C1^C5, C2^
C9, C3^C6, C4^C7, C8^C10). This is the ¢rst ¢nding of a plant
antifungal peptide with a ¢ve-disul¢de motif. EAFP1 and
EAFP2 show characteristics of hevein domain and exhibit chi-
tin-binding properties similar to the previously identi¢ed hevein-
like peptides. They exhibit relatively broad spectra of antifungal
activities against eight pathogenic fungi from cotton, wheat,
potato, tomato and tobacco. The inhibition activity of EAFP1
and EAFP2 can be e¡ective on both chitin-containing and chi-
tin-free fungi. The values of IC50 range from 35 to 155 Wg/ml
for EAFP1 and 18 to 109 Wg/ml for EAFP2. Their antifungal
e¡ects are strongly antagonized by calcium ions. 6 2002 Pub-
lished by Elsevier Science B.V. on behalf of the Federation of
European Biochemical Societies.
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1. Introduction
Though plants are constantly exposed to various microbial
pathogens, infections remain rare events. This is because
plants have evolved several e¡ective defense mechanisms to
protect themselves from pathogenic attacks. A wide array of
antimicrobial peptides and proteins are believed to be in-
volved in such mechanisms [1,2]. Among them the cysteine-
rich peptides form a large group of the antimicrobial proteins,
in which a certain disul¢de-motif stabilizes the molecular scaf-
fold [2]. Accordingly, these plant antimicrobial peptides are
usually classi¢ed by their distinct disul¢de motif and sequence
homologies (e.g. [2]). Thionins [3^5], plant defensins [6^8],
hevein-like [9^12] and knottin-like [13^15] peptides belong to
these classes. So far at most eight cysteines pairing into four
disul¢de bridges have been found in these peptides.
In this paper we report two novel antifungal peptides,
EAFP1 and EAFP2, distinguished by 10 cysteines pairing
into ¢ve disul¢de bonds from the bark of Eucommia ulmoides
Oliv (Garryales order, Eucommiaceae family), whose bark,
called Du-Zhong in Chinese, is a traditional Chinese medicine
mainly used as a tonic for reducing blood pressure and con-
tains a kind of latex similar to that of rubber tree (Hevea
brasiliensis) [9]. These two peptides are also N-terminal block-
age by pyroglutamic acid. To our knowledge this is the ¢rst
¢nding of a plant antifungal peptide with a ¢ve-disul¢de mo-
tif. The puri¢cation, complete amino acid sequence, bioassay
and comparison with hevein-like peptides will be described.
2. Materials and methods
2.1. Materials
The bark of E. ulmoides Oliv was obtained from the Kunming
mountain area of the Yun-Nan province in China. Eight strains of
plant pathogenic fungi, Phytophthora infestans, Ascochyta lycopersici,
Verticillium dahliae, Gibberella zeae, Alternaria nicotianae, Fusarium
moniliforme, Fusarium oxysporum and Colletotrichum gossypii, and
two bacterial strains, Bacillus megaterium (Gram-negative) and Pseu-
domonas syringae (Gram-Positive), were used in the bioassay.
Dithiothreitol (DTT), iodoacetamide (IAA), K-cyano-4-hydroxycin-
namic acid (CHCA), TPCK-treated trypsin and carboxypeptidase Y
(CPY) were purchased from Sigma. All other reagents were of ana-
lytical grade or high performance liquid (HPLC) grade.
2.2. Isolation and puri¢cation of EAFPs
The washed bark of E. ulmoides Oliv was cut into pieces that were
ground to power and extracted with 2 volumes of 0.5 mol/l NaCl with
pH 6.0. The supernatant was precipitated with 95% saturated solution
of (NH4)2SO4, and then isolated by CM-cellulose-52 column, gel ¢l-
tration column of Bio-gel-p-10 and Waters YWG-Pak C18 column,
successively.
2.3. MALDI-TOF mass spectrometric analysis
Matrix-assisted laser desorption ionization-time of £ight (MALDI-
TOF) mass spectra were recorded on a Bruker Pro£ex III mass spec-
trometer. The matrix was used as CHCA dissolved in 50% ACN
solution containing 0.1% tri£uoroacetic acid (TFA) to a saturated
solution. 2 Wl (about 1^5 pmol/Wl) of peptide dissolved in a 0.1%
TFA solution in water was mixed with 20 Wl of the CHCA-saturated
matrix solution. 1 Wl of this mixture was deposited on the target and
dried. The spectra were calibrated with huwentoxin-I (MW 3750.45
Da, presented by S.P. Liang [16]).
2.4. Bioassay
Antimicrobial activity was determined by agar di¡usion assay as
described by Bormann et al. [17]. Test plates (85 mm in diameter)
containing 17.5 ml of potato dextrose (PD) medium were seeded
with test organisms, either spores of ¢lamentous fungi or cells of
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bacteria. After recovering overnight at 25‡C, the solution containing
the EAFPs was applied into wells (6 mm in diameter punched into the
agar). The antifungal activities were shown by the occurrence of a
visible zone of inhibited mycelia growth after incubation at 25‡C
for 48 h.
To assay the inhibition of hyphal growth, an agar plug (6 mm in
diameter) containing mycelia of the test fungus was placed in the
center of a petri dish containing 17.5 ml of PD medium and incubated
at 25‡C until the colony reached a diameter of 3^4 cm. A paper disk
containing 20 Wl of peptide was placed at the growing front of the
hyphae and the test plates were further incubated.
The percentage of growth inhibition was assayed as described by
Broekaert et al. [12]. 20 Wl aliquots of two-fold serial diluted peptide
solution were added to a 96-well plate and mixed with 80 Wl of PD
liquid medium containing ca 1000 fungal spores. The growth was
recorded after incubating for 36 h at 25‡C. The absorption at
595 nm served as a measurement for fungal growth.
2.5. Amino acid sequencing
The puri¢ed peptides were reduced and carboxyamidomethylated
according to the method described by Liang [16] and digested with
trypsin. The tryptic peptides were puri¢ed by reverse phase HPLC.
The Edman degradation was performed on an Applied Biosystem
491 gas-phase sequencer with a normal automatic cycle program.
Tandem mass spectrometry for peptide sequencing were performed
on an APEX1 II Fourier transform ion cyclotron resonance mass
spectrometer (Bruker Daltonics). The MS/MS fragment ions are gen-
erated by introducing a 3500 Ws argon pulse with 1 mbar pressure and
interpreted according to the nomenclature proposed by Roepstor¡
and Johnson [18,19]. C-terminal sequence analysis was performed
by MALDI-TOF mass spectrometry combined with CPY time-depen-
dent and concentration-dependent digestion as described by Patterson
[20].
3. Results
3.1. Isolation and puri¢cation of EAFPs
Two kinds of antifungal peptides were puri¢ed from the
bark of E. ulmoides Oliv by the following steps: ammonium
sulfate precipitation, CM-cellulose cation exchange chroma-
tography, gel ¢ltration and reverse-phase HPLC, successively.
The e¥uents were monitored for absorbance at 280 nm and
the active fraction was traced by the antifungal assay. In the
reverse phase chromatogram two main peaks with antifungal
activity appeared and were named EAFP1 and EAFP2, re-
spectively, according to the retention time. The yield of
EAFP2 was higher than that of EAFP1. The purities of
EAFP1 and EAFP2 were evidenced by MALDI-TOF mass
spectra. The molecular weights of the native EAFP1 and
EAFP2 were determined as 4201.4 Da and 4158.9 Da, respec-
tively, by the mass spectrometry.
3.2. Amino acid sequences of EAFPs
The molecular weights of carboxyamidomethyl (CAM)
EAFP1 and EAFP2 were determined by MALDI-TOF mass
spectrometry as 4782.4 and 4739.2 Da, respectively. The
masses of CAM-EAFPs are ca. 580 Da higher than those of
the native forms, indicating that EAFP1 and EAFP2 both
contain 10 cysteines forming ¢ve pairs of disul¢de, for the
molecular weight will increase by 58 Da when half of the
cysteine is carboxyamidomethylated.
Absence of PTH peaks when the native and CAM-EAFPs
Fig. 1. A: The summary of the proof of the amino acid sequences
in EAFP1 and EAFP2. B: Comparisons of the sequences of EAFP1
and EAFP2 with those of hevein-type peptides. Sequence identities
to EAFPs are shaded in black, the additional two cysteines of
EAFPs in gray, and the activity-related residues are indicated by an
asterisk at the top. Pn-AFP, antifungal peptide from Pharbitis nil L.
[22]; hevein, rubber latex hevein [9]; Ac-AMP, antimicrobial pep-
tides from Amaranthus caudatus [12]. C: Cysteine connectivities of
EAFPs in comparison with those of hevein-type peptides. Cysteine
connectivities are shown by full lines. EAFPs are unique with a
¢ve-disul¢de motif with pairing pattern (C1^C5, C2^C9, C3^C6,
C4^C7, C8^C10).
Table 1
The sequences and masses of the tryptic fragments
EAFP1 EAFP2
Retention time
(min)
Sequence Molecular weight Retention time
(min)
Sequence Molecular weight
Exp.
[MH]þ
Theor.
[M]
Exp.
[MH]þ
Theor.
[M]
9.7 CQCR 608 622.7 9.4 CQCR ND 622.7
11.0 CGAGNCR 796 794.3 10.3 CGAGNCR 792 794.3
12.9 NDb 705 704.3 12.3 6QTCASRa 705 704.3
15.1 CPRPC 692 689.3 13.6 CPRPC 689 689.3
24.7 GYCGSGNAY 947 949.4 25.7 GYCGSGAAY 904 905.4
39.8 CPRPCNAGLCCSIY 1727 1727.7 39.4 CPRPCNAGLCCSIY 1728 1727.7
41.1 NAGLCCSIY 1057 1057.4 40.2 NAGLCCSIY 1057 1057.4
6Q, the pyroglutamic acid; ND, not detected.
aThe sequence is deduced from the tandem mass spectra and other sequences are determined by Edman degradation.
bThe sequence is believed to be the same as the N-terminal sequence of EAFP2 though not determined experimentally, for the peptide with the
molecular weight of 704 Da is also found in the peptide map of EAFP1, which has the same mass and same retention time in the peptide
map.
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are applied to Edman degradation indicated that the N-termi-
nals of EAFPs were blocked. The following experiments were
performed to obtain their sequence information. CAM-
EAFPs were digested by trypsin and the resulted peptides
were fractionated and identi¢ed by MALDI-TOF mass spec-
trometry, and then applied to Edman degradation sequencing
or tandem mass analysis. The results are summed up in Table
1. C-terminal sequences were obtained by C-terminal ladder
sequencing analysis [20]. The results showed that the C-termi-
nal sequences are R CPRPC NAGLC CSIYG vvvSG
NAYvv AGNCR CQCRG and LCC SIYG YvvSv AAYCv
vvNCR CQCRG (v is the unde¢ned residue in the mass
spectra) for EAFP1 and EAFP2, respectively, which not
only provide full sequence assembling information, but also
con¢rm the results summarized in Table 1.
From the above results the sequences of the EAFPs can be
completely deduced as shown in Fig. 1A, which are in good
agreement with the results of the amino acid analysis (data
not shown). The average molecular weights calculated from
the sequences are 4211.80 Da and 4168.77 Da for EAFP1 and
EAFP2, respectively, which are about 10 Da higher than the
experimental value. This result further supports the supposi-
tion that each of the 10 cysteines of the EAFPs loses a hydro-
gen atom to form ¢ve pairs of disul¢de bond.
3.3. Antifungal activity of EAFPs
The antifungal activity and the antifungal spectra of EAFPs
were determined by Agar di¡usion assay. The spectra of anti-
fungal activity of EAFPs are relatively broad. The EAFPs can
inhibit all examined phytopathogenic fungi including P. infes-
tans, A. lycopersici, V. dahliae, G. zeae, A. nicotianae, F. moni-
liforme, F. oxysporum, C. gossypii. In contrast, EAFPs have
no e¡ect on the growth of the tested Gram-negative bacterium
B. megaterium and Gram-positive bacterium P. syringae. In
addition, EAFP1 and EAFP2 also signi¢cantly inhibit hyphal
growth of the above fungi, of which C. gossypii is the most
sensitive. The crescent-shaped zone of inhibition for C. gossy-
pii can be stable for over two weeks. The spores of A. lyco-
persici, F. moniliforme, F. oxysporum and C. gossypii were
collected for the percentage growth inhibition assay. IC50 val-
ues were derived from dose^response curves (percentage of
growth inhibition versus protein concentration) and are listed
in Table 2. EAFP1 and EAFP2 show similar antifungal activ-
ities with IC50, ranging from 35 to 155 Wg/ml and 18 to 109
Wg/ml, respectively. There are no synergistic e¡ects between
these two peptides (Fig. 2). When calcium ions are added to
the PD liquid medium, IC50 values rise more than 100-fold
(Fig. 2), which shows that 5 mM calcium ion can signi¢cantly
inhibit the antifungal activity of EAFPs.
Polysaccharide binding assay was carried out. In the experi-
ment EAFPs exhibit a potent a⁄nity with chitin and have no
binding a⁄nity with xylan (data not shown).
4. Discussion
The automated Edman degradation in combination with
the tandem mass spectrometry and C-terminal ladder sequenc-
ing analysis determined the full sequences of antifungal pep-
tides EAFP1 and EAPF2, which both contain 41 residues
with the N-terminal blockage by pyroglutamic acid (Fig.
1A). The most striking feature of their structures is 10 cys-
teines cross-linked to form ¢ve disul¢de bonds. The connec-
tivities of these disul¢de bridges can be reasonably deduced
from the sequence alignment between EAFPs and hevein (Fig.
1B). Among 10 cysteines in EAFPs, eight (C1, C3, C4, C5,
C6, C7, C8 and C10) are identical to those in hevein with
regard to characteristic arrangement and distinctive residues
(CS, CG, YC) for the hevein-type peptides (Fig. 1B). There-
fore, they should adopt the connectivities (C1^C5, C3^C6,
C4^C7, C8^C10) corresponding to those in hevein (C1^C4,
C2^C5, C3^C6, C7^C8). Since all 10 cysteines are contained
in the disul¢de bridges as shown in the results, the additional
two cysteines (C2 and C9) in EAFPs must connect with each
other. Consequently, it is rational to predict that the connec-
tivities of the 10 cysteines of EAFPs should be C1^C5, C2^
C9, C3^C6, C4^C7 and C8^C10, which have been identi¢ed
Fig. 2. A, B: The antifungal activity of EAFP1 (A) and EAFP2 (B)
against fungus C. gossypii. C: The antagonistic e¡ect of Ca2þ on
the antifungal activity of EAFP2. D: The mixture of EAFP1 and
EAFP2 in equal amounts.
Table 2
Antifungal activities of EAFP1 and EAFP2
Fungus IC50 (Wg/ml)
EAFP1 EAFP2 EAFP1+EAFP2 Ca2þ+EAFP2
A. lycopersici 155 109 ND ND
F. moniliforme 56 18 ND ND
F. oxysporum 46 94 ND ND
C. gossypii 35 56 37 s 1000
ND, not detected.
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by preliminary X-ray structure analysis at 0.8 AV resolution
(Xiang et al., personal communication). This form of connec-
tivities is di¡erent from the pattern (C1^C4, C2^C5, C3^C6,
C7^C8) in hevein (Fig. 1C). To our knowledge, from a struc-
tural point of view, this is a novel type of antifungal peptide
identi¢ed so far.
The sequence alignment (Fig. 1B) indicated that, as de-
scribed above, the core of EAFPs is a hevein domain [2]
that shows the same cysteine pairing and unique residues as
Gly, Ser and Tyr as in hevein [9]. However, the additional
disul¢de bridge (C2^C9) in EAFPs cross-links the N-terminal
with the C-terminal, which should promote certain structural
features to the general folding pattern appearing in this type
of peptides. The bioassay showed that, except for inhibition to
a series of chitin-containing fungi, EAFPs could also be
against a chitin-free fungus, P. infestans. This result provides
a functional evidence, showing the certain peculiarity of
EAFP structure. The ¢nding of EAFPs also extends the
known families of chitin-binding proteins [2,21] with its
unique ¢ve-disul¢de motif. Certainly, the detailed structural
features of EAFPs should be clari¢ed by the three-dimension-
al structure.
The Eucommia antifungal peptide molecules containing 41
residues with ¢ve disul¢de bonds must be very solid and ex-
tremely stable. In fact, they can retain their antifungal activity
in boiled water for 30 min (data not shown), and are easily
crystallized, in contrast with other small peptides. This solid
folding pattern may favor penetration through the fungal cell
wall. The bioassay showed that they exhibited evident e¡ects
on a relatively broad spectrum against fungi, including a series
of pathogens for cotton, wheat, potato, tomato and tobacco.
The e¡ective fungi include both chitin-containing and chitin-
free fungi. The activity of EAFP1 and EAFP2 is nearly sim-
ilar, which shows that the micro-heterogeneous substitute at
residue 27 (Fig. 1A) does not a¡ect the antifungal activity.
The antifungal e¡ects of EAFPs can be strongly antagonized
by calcium ion. For all these properties in association with the
peculiar primary structure the molecular mechanism of the
antifungal activity for EAFPs becomes very interesting.
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